Biologic Videos
-
AustinPX Site Tour
5/2/2025
Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.
-
CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity
4/30/2025
Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.
-
White Raven's Accelerated Path To GMP Certification
4/28/2025
CDMO White Raven achieved GMP certification using an innovative aseptic filling solution in just 18 months. Discover how meticulous planning and collaboration set a new industry standard for efficiency.
-
Service Solutions Designed To Help You Gain Speed To Clinic And Market
4/28/2025
Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.
-
Cambrex Capacity Update April 2025: Small Molecule
4/23/2025
Matthew Bio, Ph.D., President of Snapdragon Chemistry and Chief Scientific Officer of Cambrex, presents the company’s capabilities in the development of peptide therapeutics.
-
Bend Bioscience Capacity Update April 2025: Small Molecule
4/23/2025
Leverage expert small molecule solutions, from pre-clinical development to commercial manufacturing, with specialized capabilities in large-scale oral solid dosage, advanced formulations, controlled substances, and high-potency compounds.
-
Northway Biotech Capacity Update April 2025: Large Molecule Development
4/22/2025
Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO.
-
Abzena Capacity Update April 2025: Large Molecule Development
4/22/2025
Discover how an evolved approach to cell line development with AbZelectPRO™ can simplify selection, enhance stability, and de-risk your biologics program for faster, more confident regulatory approval.
-
Curia Capacity Update April 2025: Large Molecule Development
4/22/2025
Learn how a true scientific partnership and seamless development support can help accelerate your path from discovery to clinic.
-
Cytovance Biologics Capacity Update April 2025: Large Molecule Development
4/22/2025
Discover how end-to-end microbial and mammalian biologics development and manufacturing expertise — spanning everything from biosimilars to vaccines — can help accelerate your program with flexible capacity and proven ingenuity.